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Introduction {#jdi12854-sec-0005}
============

Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance resulting in hyperglycemia with first onset or detection during pregnancy. GDM is seriously harmful to both the woman and the fetus. Pregnant women and puerperae are prone to complications of gestational hypertensive disease, polyhydramnios, premature rupture of fetal membranes, infection and premature birth; in severe cases, ketoacidosis can occur, and puerperae might have long‐term postpartum diabetes[1](#jdi12854-bib-0001){ref-type="ref"}, [2](#jdi12854-bib-0002){ref-type="ref"}. In addition, the fetus is prone to spontaneous abortion, malformation and hypoxia; in severe cases, intrauterine death can occur. Hyperglycemia tends to cause fetal macrosomia; the chances of dystocia at parturition are increased, and the newborn is prone to neonatal respiratory distress syndrome, hypoglycemia and other complications after birth, including death in severe instances[3](#jdi12854-bib-0003){ref-type="ref"}.

In 2008, the hyperglycemia and adverse pregnancy outcome (HAPO) study, which involved multiple countries, showed that at 24--32 weeks‐of‐gestation, a higher blood glucose level in the 75‐g oral glucose tolerance test (OGTT) indicates a greater risk of adverse gestational outcomes. Indeed, even with a normal blood glucose level, the risk of having an adverse outcome for both mother and baby is greater with an increase in blood glucose level, whereas significant thresholds were not observed for most comorbidities. Based on that study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed new GDM diagnostic criteria in 2010: boundary blood glucose levels for fasting, 1 and 2 h after oral glucose of 5.1, 10.0 and 8.5 mmol/L, respectively, by 75‐g OGTT. If any one of these three values reaches or exceeds the boundary level, the patient should be diagnosed with GDM[4](#jdi12854-bib-0004){ref-type="ref"}. The publication of this diagnostic standard had a "milestone" significance. In 2011, the American Diabetes Association (ADA) recommended the IADPSG criteria be adopted as GDM diagnostic criteria, and in August 2013, the World Health Organization (WHO) used the HAPO study results as an important reference to develop new GDM diagnostic criteria[5](#jdi12854-bib-0005){ref-type="ref"}. In 2014, the ADA once again noted that although the new diagnostic criteria would increase healthcare costs, they might also reduce the incidence of adverse gestation events, especially for pregnant women with slightly high blood glucose levels. In October 2015, the International Federation of Gynecology and Obstetrics published a practical guide to GDM, which also utilizes the IADPSG criteria to diagnose GDM[6](#jdi12854-bib-0006){ref-type="ref"}.

As a result of economic development and improvements in living standards, together with increased attention to GDM screening, an increase has been observed in the incidence of GDM. China has a high incidence of diabetes, and the increase in GDM incidence in China is also alarming. Furthermore, China encompasses a vast territory, and has a large population with considerable differences in regions, ethnicities, diets and living habits, and these factors lead to differences in the incidence of GDM reported in various regions. For example, studies have found that even if the IADPSG diagnostic criteria are applied, the incidence of GDM in mainland China fluctuates between 5.12% and 33.3%[7](#jdi12854-bib-0007){ref-type="ref"}, [8](#jdi12854-bib-0008){ref-type="ref"}. As there is currently no systematic analysis of the incidence of GDM in China, the present study aimed to explore the incidence of GDM among pregnant women in mainland China, and the impact of relevant factors on GDM incidence through a systematic meta‐analysis.

Methods {#jdi12854-sec-0006}
=======

A completed Preferred Reporting Items for Systematic Review and Meta‐Analyses checklist is presented in Data [S1](#jdi12854-sup-0001){ref-type="supplementary-material"}.

Search strategy {#jdi12854-sec-0007}
---------------

We searched for epidemiological studies on GDM in several electronic databases, including Medline, PubMed, China National Knowledge Infrastructure, Wanfang and Chongqing VIP. Each search strategy is listed as follows. Medline: (TS = gestational diabetes mellitus OR TS = GDM) AND (\[TS = prevalence\] OR TS = epidemi\*) AND (\[(TS = Chinese) OR TS = China\] OR TS = mainland); Pubmed: (\[gestational diabetes mellitus(Title/Abstract)\] OR GDM(Title/Abstract)\] AND \[(prevalence(Title/Abstract)\] OR epidemi\*\[Title/Abstract\]) AND (\[(Chinese\[Title/Abstract\]) OR China\[Title/Abstract\]) OR mainland\[Title/Abstract\]); China National Knowledge Infrastructure: AB = gestational diabetes mellitus AND (AB = prevalence OR AB = epidemiology); Wangfang: Abstract: (gestational diabetes mellitus)\*(prevalence + epidemiology). Chongqing VIP: R = gestational diabetes mellitus\*(R = prevalence + R = epidemiology). All studies published from 1 January 2010 to 30 April 2017, were searched. In addition, the reference lists of the retrieved articles were examined to identify additional eligible studies. Unpublished studies were not retrieved. The search languages were limited to English and Chinese.

Inclusion and exclusion criteria {#jdi12854-sec-0008}
--------------------------------

To satisfy the analysis requirements and to reduce selection deviation, studies needed to meet the following criteria for inclusion: (i) a cross‐sectional study or retrospective study collected in mainland China; (ii) sufficient information on the sample size and crude prevalence of GDM; (iii) GDM diagnostic criteria proposed by IADPSG in 2010[4](#jdi12854-bib-0004){ref-type="ref"}; (iv) containing information for at least family history of diabetes mellitus, body mass index (BMI), age, pregnancy history and delivery history. Studies were excluded if they recruited patients with serious and chronic diseases, including thyroid disease, heart disease and overt diabetes mellitus. In the case of multiple articles based on the same population, only the study reporting the most detailed data was included.

Data extraction and quality assessment {#jdi12854-sec-0009}
--------------------------------------

All searched articles from different electronic databases were combined in Endnote, and duplicates were removed. Two researchers independently screened the title and abstract, and reviewed the full text of eligible citations. In the case of disagreement, a third reviewer made the final decision. For each included study, the two researchers independently extracted the following information: general information (e.g., first author and publication year), study characteristics (including study period, study area and sample size) and all possible participant information (e.g., age, family history of diabetes mellitus, BMI, region etc.). The two researchers independently assessed the quality of each included study using the Newcastle--Ottawa Scale recommended by the Cochrane Handbook for Systematic Reviews of Interventions.

Statistical analysis {#jdi12854-sec-0010}
--------------------

We used a systematic analysis approach to calculate the pooled prevalence of GDM for all eligible studies. A random effects model was selected to summarize the prevalence of GDM; heterogeneity among studies was assessed using Cochran\'s *Q*‐test and the *I* ^2^ statistic, which shows the percentage of variation across studies. Subgroup analyses by age, family history of diabetes mellitus, BMI, region and so on were carried out to address heterogeneity. Additionally, sensitivity analysis was carried out to examine the influence of any particular study on the pooled estimate. Publication bias was evaluated using Egger\'s test, and independent *t*‐tests were carried out as appropriate. The significance level was set at a *P*‐value of \<0.05. All statistical analyses were carried out using Stata version 12.0 (StataCorp, College Station, TX, USA) and SPSS version 20.0 (SPSS Inc., Chicago, IL, USA).

Results {#jdi12854-sec-0011}
=======

The initial search retrieved 2,576 records from Medline, PubMed, China National Knowledge Infrastructure, Wanfang and Chongqing VIP databases, and 508 articles remained after excluding duplicates, reviews and letters. After screening for eligibility based on the title and abstract, 107 articles were selected; of these, 25 articles were included after screening the full text. The main reasons for inclusion in the full‐text selection are shown in Figure [1](#jdi12854-fig-0001){ref-type="fig"}, [7](#jdi12854-bib-0007){ref-type="ref"}, [8](#jdi12854-bib-0008){ref-type="ref"}, [9](#jdi12854-bib-0009){ref-type="ref"}, [10](#jdi12854-bib-0010){ref-type="ref"}, [11](#jdi12854-bib-0011){ref-type="ref"}, [12](#jdi12854-bib-0012){ref-type="ref"}, [13](#jdi12854-bib-0013){ref-type="ref"}, [14](#jdi12854-bib-0014){ref-type="ref"}, [15](#jdi12854-bib-0015){ref-type="ref"}, [16](#jdi12854-bib-0016){ref-type="ref"}, [17](#jdi12854-bib-0017){ref-type="ref"}, [18](#jdi12854-bib-0018){ref-type="ref"}, [19](#jdi12854-bib-0019){ref-type="ref"}, [20](#jdi12854-bib-0020){ref-type="ref"}, [21](#jdi12854-bib-0021){ref-type="ref"}, [22](#jdi12854-bib-0022){ref-type="ref"}, [23](#jdi12854-bib-0023){ref-type="ref"}, [24](#jdi12854-bib-0024){ref-type="ref"}, [25](#jdi12854-bib-0025){ref-type="ref"}, [26](#jdi12854-bib-0026){ref-type="ref"}, [27](#jdi12854-bib-0027){ref-type="ref"}, [28](#jdi12854-bib-0028){ref-type="ref"}, [29](#jdi12854-bib-0029){ref-type="ref"}, [30](#jdi12854-bib-0030){ref-type="ref"}, [31](#jdi12854-bib-0031){ref-type="ref"}. The 25 articles that met the requirements and were eventually included in the study covered the prevalence of GDM in pregnant women in 21 regions of mainland China between 2010 and 2017, including 79,064 participants. The characteristics of the selected studies are summarized in Table [1](#jdi12854-tbl-0001){ref-type="table"}. Among the included articles, 24 focused on women of Han nationality, one involved other ethnic groups and two included a multiple pregnancy. The economic levels of the regions in the included papers had per capita annual incomes ranging from less than \$US1,000 to \$US30,000, and the papers included age, family history of diabetes mellitus, history of pregnancy and delivery, BMI, per capita income, and many other factors that affect GDM. In accordance with the recommended criteria of the Newcastle--Ottawa Scale, the studies included in the present meta‐analysis were of acceptable quality; therefore, we did not exclude any article from the meta‐analysis for quality reasons.

![Flow chart showing the detailed procedure for the inclusion or exclusion of studies.](JDI-10-154-g001){#jdi12854-fig-0001}

###### 

Study characteristics of the published studies included in the meta‐analysis

  Study            Period                   Sample (*n*)   Region (province)   Economic level[a](#jdi12854-note-0001){ref-type="fn"}   Native   Maternal age (year)   Gestational age (weeks)   Case    Subgroup of risk factor[b](#jdi12854-note-0002){ref-type="fn"}        Prevalence   Other confounders
  ---------------- ------------------------ -------------- ------------------- ------------------------------------------------------- -------- --------------------- ------------------------- ------- --------------------------------------------------------------------- ------------ -----------------------------------------------------------------------------------------------------------------------------------------
  Chen Y, 2013     Sep 2012 to Mar 2013     410            Xinjiang            Low                                                     Yes      27.07 ± 0.42          25.1 ± 0.22               21      Age, BMI                                                              5.12%        Multiple race included, maternity hospital
  Li GP, 2015      Dec 2012 to Feb 2014     690            Henan               Low                                                     Yes      28.9 ± 4.17           14.4 ± 2.8                230     Age, BMI                                                              33.3%        Comprehensive hospital
  Chen JY, 2014    Jan 2012 Jun 2013        850            Shenzhen            High                                                    No       25.5 ± 1.75           24--28                    82      Age, pregnancy history, BMI                                           9.65%        Comprehensive hospital
  Gu Q, 2016       Jan 2013 Dec 2014        845            Jiangsu             High                                                    Yes      --                    24--28                    140     Age                                                                   16.57%       Primary hospital
  Chen XW, 2016    Jan 2014 Oct 2015        3098           Jiangsu             High                                                    Yes      18--45                24--28                    384     Age                                                                   12.4%        Primary hospital
  Liu J, 2016      Jan--Jun 2014            1861           Shandong            Low                                                     Yes      --                    24--28                    406     Age, BMI, family history of DM, pregnancy history, delivery history   21.82%       Maternity hospital
  Li XJ, 2014      Jun 2013.6 to Mar 2014   1288           Tianjin             High                                                    Yes      --                    24--28                    294     Age, BMI, family history of DM                                        22.8%        Maternity hospital
  Hao BJ, 2014     Oct 2012 to Dec 2013     1250           Guangzhou           High                                                    Yes      30.4 ± 4.32           24--28                    165     Age                                                                   13.2%        Comprehensive hospital
  Wu JH, 2016      Jan 2015 to Jun 2016     1723           Jiangsu             High                                                    Yes      28.5 ± 4.3            25.3 ± 2.4                102     Age                                                                   5.92%        Primary hospital
  Wang XR, 2014    Nov 2012 to Jun 2013     1132           Liaoning            High                                                    Yes      --                    24--28                    136     Age, BMI, family history of DM, pregnancy history, delivery history   12.07%       Maternity hospital
  Xu X, 2015       Jan 2012 to Dec 2013     2748           Jiangsu             High                                                    Yes      --                    24--28                    540     Age, BMI, family history of DM                                        19.65%       Comprehensive hospital
  Zeng SY, 2015    Jan 2013 Dec 2014        2032           Jiangxi             Low                                                     Yes      --                    24--28                    225     Age, BMI, family history of DM, pregnancy history, delivery history   11.07%       Comprehensive hospital
  Zhang CJ, 2016   Jan--Oct 2014            3134           Jiangsu             High                                                    Yes      29.8 ± 2.9            22--40                    596     Age, BMI, delivery history                                            19%          Maternity hospital
  Guo HJ, 2016     Jan--Dec 2014            2588           Shanghai            High                                                    No       --                    24--28                    241     Age, pregnancy history, delivery history                              9.31%        Multiple pregnancy included, comprehensive hospital
  Wang JJ, 2016    Jun--Nov 2013            965            Beijing             High                                                    Yes      --                    24--28                    125     BMI, family history of DM                                             12.95%       Comprehensive hospital
  Liu ZG, 2014     Apr 2013 to Jun 2014     951            Jiangxi             Low                                                     Yes      1,742                 24--28                    182     Age                                                                   19.45%       Primary hospital
  Liu HW, 2016     Jul 2011 to Apr 2014     1529           Hebei               Low                                                     Yes      26.6 ± 5.29           24--28                    275     Age                                                                   17.98%       Maternity hospital
  Li QY, 2016      2012--2014               1035           Hebei               Low                                                     Yes      29.5 ± 3.4            24--28                    82      Age, family history of DM                                             7.92%        Comprehensive hospital, rural and urban population included
  Feng L, 2016     2007--2015               21371          Beijing             High                                                    Yes      --                    24--32                    2,577   Age                                                                   12.1%        Comprehensive hospital
  Diao YF, 2016    Jun--Sep 2015            4431           Hebei               Low                                                     Yes      --                    24--28                    372     Age, BMI                                                              8.4%         Comprehensive hospital, rural and urban population included
  Zhang J, 2016    Mar 2013 to Apr 2014     719            Sichuan             High                                                    Yes      29.2 ± 4.4            24--28                    124     Age, BMI                                                              17.2%        Multicenter clinical study include primary and comprehensive hospital
  Su RN, 2016      Jun--Nov 2013            15194          Beijing             High                                                    Yes      28.3 ± 4.3            24--28                    2,987   Age, BMI, family history of DM, delivery history                      19.7%        Multiply pregnancy included, rural and urban population included, multicenter clinical study include primary and comprehensive hospital
  Chen HT, 2017    Jun--Dec 2013            6224           Guangzhou           High                                                    Yes      --                    24--28                    1,147   Age, BMI, family history of DM, delivery history                      18.4%        Rural and urban population included, multicenter clinical study include primary and comprehensive hospital
  Li GP, 2017      Jul 2014 to Jan 2015     1401           Zhejiang            High                                                    Yes      --                    24--28                    156     Age, BMI                                                              11.1%        Primary hospital
  Mao LJ, 2015     May 2013 to Sep 2014     1595           Anhui               Low                                                     Yes      26.69 ± 3.64          24--28                    235     Age, BMI, pregnancy history, delivery history                         14.7%        Comprehensive hospital, rural and urban population included

The economic levels of the regions in the included papers had per capita annual incomes ranging from less than \$US1,000 to \$US30,000, and we used the per capita income of \$US10,000 as a boundary between low and high.

Subgroup of risk factor referred to the article included in the meta‐analysis provided enough case information in different subgroups (the number of gestational diabetes mellitus patients in maternal age, body mass index \[BMI\], family history of diabetes mellitus (DM), pregnancy history, delivery history).

John Wiley & Sons, Ltd

The total incidence of GDM in mainland China was 14.8% (95% confidence interval \[CI\] 12.8--16.7%; Figure [2](#jdi12854-fig-0002){ref-type="fig"}). Table [2](#jdi12854-tbl-0002){ref-type="table"} shows the results of subgroup analysis in different groups. Subgroup analysis showed an incidence of GDM in older pregnant women of 26.7% (95% CI 23.2--30.3%), whereas that in younger pregnant women was just 13.4% (95% CI 11.0--15.7%), with a significant difference between the two subgroups (*P *\< 0.01). The incidence of GDM in overweight or obese women was 30.3% (95% CI 25.9--34.7%), which was significantly higher than that of women who had a normal bodyweight (14.9%, 95% CI 11.7--18.1%; *P *\< 0.01). The incidence of GDM in women with a family history of diabetes mellitus was 32.9% (95% CI 27.5--38.4%), approximately threefold that in women without a family history (*P *\< 0.01). Using the per capita income of \$US10,000 as a boundary, the regional economic level did not have a significant impact on the incidence of GDM (14.8% and 15.4%, *P *= 0.53). We carefully and comprehensively searched the articles in the database. Sensitivity analysis was carried out to examine the influence of any particular study in Figure [3](#jdi12854-fig-0003){ref-type="fig"}. To determine whether potential publication bias existed in the reviewed literature, Egger\'s test was also carried out. The results of Egger\'s test (*P* = 0.437) did not suggest the existence of publication bias.

![Forest plots for total incidence of gestational diabetes mellitus (GDM) in mainland China. The diamond represents the pooled odds ratio and 95% confidence interval.](JDI-10-154-g002){#jdi12854-fig-0002}

###### 

Random effects analysis of multivariate risks of prevalence of gestational diabetes mellitus (GDM) in mainland China

  Category               Subgroup   No. study           Prevalence % (95% CI)   Sample (*n*)   *I* ^2^   *P*
  ---------------------- ---------- ------------------- ----------------------- -------------- --------- --------
  Total                             25                  14.8 (12.8--16.7)       79,064         0.984     
  Age (years)            \>35       20                  26.7 (23.2--30.3)       4,493          0.838     \<0.01
  \<35                   20         13.4 (11--15.7)     61,689                  0.988                    
  BMI                    Normal     13                  14.9 (11.7--18.1)       32,057         0.984     \<0.01
  Obese                  13         30.3 (25.9--34.7)   7,623                   0.931                    
  Family history of DM   Yes        9                   32.9 (27.5--38.4)       3,012          0.807     \<0.01
  No                     9          13.7 (9.9--17.6)    23,869                  0.984                    
  Pregnancy history      Yes        5                   12.1 (9.1--15.0)        4,599          0.898     0.33
  No                     5          15.2 (10.8--19.6)   4,609                   0.959                    
  Delivery history       Yes        4                   20.2 (18.3--22.2)       11,477         0.788     0.03
  No                     4          16.5 (13.7--19.3)   14,429                  0.918                    
  Economic level         High       16                  14.8 (12.1--16.8)       64,530         0.984     0.53
  Low                    9          15.4 (11.2--19.6)   14,534                  0.983                    
  Area                   Southern   14                  20.3 (6.9--33.8)        29,158         0.999     0.62
  Northern               11         15.7 (12.4--19.0)   49,906                  0.989                    

BMI, body mass index; CI, confidence interval; DM, diabetes mellitus.

John Wiley & Sons, Ltd

![The results of sensitivity analysis of the meta‐analysis.](JDI-10-154-g003){#jdi12854-fig-0003}

Discussion {#jdi12854-sec-0012}
==========

As early as 1964, O\'Sullivan and Mahan[32](#jdi12854-bib-0032){ref-type="ref"} suggested screening for high‐risk pregnant women and, for the first time, proposed diagnostic criteria for GDM, whereby patients should be diagnosed with GDM when blood glucose levels are equal to or greater than boundary values for fasting, 1, 2 and 3 h after oral glucose of 5.0, 9.2, 8.1 and 7.0 mmol/L, respectively, according to the 100‐g OGTT. In 1973, O\'Sullivan *et al* [33](#jdi12854-bib-0033){ref-type="ref"} proposed a 50‐g OGTT; if the blood glucose level was ≥7.2 mmol/L 1 h after glucose load, then the 100‐g OGTT was carried out. The results of a number of subsequent studies showed that for GDM screening, it is most suitable to use 7.8 mmol/L as the boundary value for a blood glucose level at 1 h after glucose load, a value that is still used today. In 1979, the National Diabetes Data Group modified the diagnostic criteria of GDM based on O\'Sullivan\'s standard[34](#jdi12854-bib-0034){ref-type="ref"}. In this case, the patient should be diagnosed with GDM when plasma glucose levels are ≥2 boundary points of the values for fasting, 1, 2 and 3 h after glucose load of 5.8, 10.6, 9.2 and 8.1 mmol/L, respectively. In 1982, Carpenter[35](#jdi12854-bib-0035){ref-type="ref"} recommended that the plasma glucose boundary values for fasting, 1, 2 and 3 h after taking glucose be 5.3, 10.0, 8.6 and 7.8 mmol/L, respectively, with GDM diagnosis at levels ≥2 boundary points. In 1998, this standard was recommended for application by the ADA, but the glucose load was changed from 100 to 75 g, and the 3‐h blood glucose value was removed. As guidelines for the diagnosis and classification of diabetes were issued by the WHO in 1965, in 1999, it recommended after three discussions that patients should be diagnosed with GDM when fasting plasma glucose is ≥7.0 mmol/L or 2‐h blood glucose is 11.1 mmol/L. Although the NDGG, ADA and WHO standards have been used for many years, for the past 50 years, the diagnostic methods and standards for GDM have been the subject of controversy. Both the standard proposed by O\'Sullivan and the later National Diabetes Data Group or ADA standard are all based on the risk of a pregnant woman developing type 2 diabetes, but these standards lacked any consideration of gestational outcome. The WHO standard, which directly evolved from the non‐pregnant standard, also had shortcomings when it was directly applied to pregnancy. In 2010, the IADPSG proposed a new standard for GDM diagnosis based on the HAPO study, and in this same year, the ADA recommended adoption of the IADPSG standard as the new diagnostic standard for GDM. The 2011 edition of the GDM health industry standards by the Ministry of Health of China, the 2013 edition of the Chinese Guidelines for the Diagnosis and Treatment of Diabetes Mellitus, and the 2014 edition of the Guidelines for the Diagnosis and Treatment of Gestational Diabetes Mellitus all adopted the IADPSG standard.

The present study is the first meta‐analysis of the incidence of GDM according to the IADPSG standard in mainland China. This study found an incidence of GDM in mainland China of 14.8%, which is similar to the reported incidence of GDM in Hong Kong -- 14.4% by the HAPO multicenter study[36](#jdi12854-bib-0036){ref-type="ref"}. Although the incidence of GDM in mainland China is lower than that in the USA, Singapore and other developed nations, considering China\'s huge population, it is speculated that China might have the largest number of GDM patients. In addition, the incidence of GDM in China shows a clear upward trend. For example, the incidence of GDM in Tianjin, China, increased almost threefold from 1999 to 2008. Therefore, closer attention should be paid to GDM in China[37](#jdi12854-bib-0037){ref-type="ref"}.

The results of subgroup analysis showed that the incidence of GDM in older women in China was 26.7%, though the incidence of GDM in younger women was just 13.4%; thus, the incidence of GDM among older women was approximately twice that among younger women. As China\'s fertility policy changes, divorce and remarriage rates increase, and multiparous women might have more children due to the death of offspring as a result of disease or accidents; thus, the incidence of advanced maternal age among pregnant women will continue to increase in China. Apart from the factor of age, the incidence of GDM in women with a family history of diabetes was threefold as high as that of women without a family history, suggesting that a family history of diabetes significantly increases the incidence of GDM. In addition, overweight or obesity also showed significant impacts on the incidence of GDM. Conversely, we found that the per capita economic levels of the 21 cities included did not influence the incidence of GDM. We suggest that this apparent lack of influence might be related to the mixed effects of diet, lifestyle, region and many other factors.

China is a multi‐ethnic country, with the Han nationality as the main group. In the present study, the incidence of GDM among women of the Kirgiz nationality of Xinjiang was lower than that of the Han nationality, but only one study was included. In addition, some studies have found the incidence of GDM in multiparous women to be higher than that of women with a single pregnancy; again, the sample size was small, and thus, further study is required.

The limitation of the present study was that the main data from the studies included were from large‐scale comprehensive hospitals and specialist hospitals; as only a few studies were multicenter, multilevel studies, the data lacked results from grass‐roots hospitals. Furthermore, the study participants were mainly from urban populations; studies on the prevalence of GDM in pregnant women in China\'s rural areas are rare, which will impact the calculation of the total prevalence of GDM in mainland China. We hope that there will be more epidemiological studies on GDM in grass‐roots hospitals and in rural populations in the future.

To the best of our knowledge, the present systematic review is the first to estimate the pooled prevalence of GDM among women in mainland China according to IADPSG criteria. The results of the present systematic review suggest that the total incidence of GDM in mainland China is 14.8%, indicating that China might have the largest number of GDM patients. Therefore, more attention should be paid to the prevention and control of GDM.
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